4.3 Article

Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin-exenatide study

Journal

BMC ENDOCRINE DISORDERS
Volume 22, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12902-022-00932-9

Keywords

Type 2 diabetes; GLP-1 receptor agonist; Continuous glucose monitoring; Gastric emptying

Funding

  1. AstraZeneca

Ask authors/readers for more resources

The study investigated the effects of switching from exenatide twice-daily formulation (BID) to once-weekly formulation (QW) on blood glucose fluctuation, gastric emptying, and vascular endothelial function in patients with type 2 diabetes. The results showed that postprandial glucose levels increased after switching, but glycemic variability (GV) remained relatively stable and there was no significant deterioration in vascular endothelial function. This supports the superiority of exenatide QW over exenatide BID in clinical practice, but proper monitoring and management of postprandial glucose levels should be emphasized.
Background: We investigated the changes in blood glucose fluctuation, gastric emptying, and vascular endothelial function by switching from an exenatide twice-daily formulation (BID) to a once-weekly formulation (QW) since the evaluation of postprandial glucose excursion and glycemic variability (GV) by continuous glucose monitoring (CGM) after switching was lacking. Methods: Twenty-nine patients with type 2 diabetes treated with exenatide BID were included in this study and switched to exenatide QW for 24 weeks. GV assessed by CGM, gastric emptying (by C-13-acetate breath test) and vascular endothelial function (by reactive hyperemia - peripheral arterial tonometry) were evaluated at baseline and 24 weeks after switching. Results: HbA1c decreased significantly from the baseline to week 24, while postprandial glucose levels after breakfast and dinner significantly increased (both P <0.05). However, the increases in GV indices were modest and not statistically significant at week 24. Vascular endothelial function was also not significantly changed after switching (P >0.05). Gastric emptying was significantly accelerated at week 24 (T-max 83.4 +/- 12.1 min vs. 58.2 +/- 16.4 min) (P <0.001) and correlated with increased postprandial glucose levels after breakfast and dinner (both P <0.05). Conclusions: Despite the increase in postprandial glucose associated with accelerated gastric emptying after switching from exenatide BID to QW, change in GV was modest and no significant deterioration in vascular endothelial function was observed after switching. These results support the superiority of treatment with exenatide QW over exenatide BID in clinical practice; however, attention should be paid to the monitoring and management of postprandial glucose levels when selecting exenatide QW.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available